M
Mei Ding
Researcher at Swiss Institute of Allergy and Asthma Research
Publications - 12
Citations - 1389
Mei Ding is an academic researcher from Swiss Institute of Allergy and Asthma Research. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 4, co-authored 6 publications receiving 387 citations. Previous affiliations of Mei Ding include Wuhan University.
Papers
More filters
Journal ArticleDOI
Risk factors for severe and critically ill COVID-19 patients: A review.
Ya-dong Gao,Mei Ding,Mei Ding,Xiang Dong,Jin-jin Zhang,Ahmet Kursat Azkur,Dilek Azkur,Hui Gan,Yuan-Li Sun,Wei Fu,Wei Li,Hui-ling Liang,Yiyuan Cao,Qi Yan,Can Cao,Hong-yu Gao,Marie-Charlotte Brüggen,Willem van de Veen,Milena Sokolowska,Mübeccel Akdis,Cezmi A. Akdis +20 more
TL;DR: In this review, the scientific evidence on the risk factors of severity of COVID‐19 are highlighted and socioeconomic status, diet, lifestyle, geographical differences, ethnicity, exposed viral load, day of initiation of treatment, and quality of health care have been reported to influence individual outcomes.
Journal ArticleDOI
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
Urszula Radzikowska,Urszula Radzikowska,Mei Ding,Mei Ding,Ge Tan,Ge Tan,Damir Zhakparov,Yaqi Peng,Paulina Wawrzyniak,Ming Wang,Shuo Li,Hideaki Morita,Can Altunbulakli,Matthias Reiger,Avidan U. Neumann,Avidan U. Neumann,Nonhlanhla Lunjani,Claudia Traidl-Hoffmann,Kari C. Nadeau,Liam O'Mahony,Liam O'Mahony,Cezmi A. Akdis,Milena Sokolowska +22 more
TL;DR: The aim of this study was to analyze the expression of known and potential SARS‐CoV‐2 receptors and related molecules in the extensive collection of primary human cells and tissues from healthy subjects of different age and from patients with risk factors and known comorbidities of COVID‐19.
Posted ContentDOI
Risk factors for severe and critically ill COVID-19 patients: a review
Ya-dong Gao,Mei Ding,Mei Ding,Xiang Dong,Jin-jin Zhang,Ahmet Kursat Azkur,Dilek Azkur,Hui Gan,Yuan-Li Sun,Wei Fu,Wei Li,Hui-ling Liang,Yiyuan Cao,Qi Yan,Can Cao,Hong-yu Gao,Marie-Charlotte Brüggen,Willem van de Veen,Milena Sokolowska,Mübeccel Akdis,Cezmi A. Akdis +20 more
TL;DR: The scientific evidence on the risk factors of COVID-19 is highlighted and the development of a cytokine storm and extensive chest computed tomography imaging patterns are indicators of a severe disease.
Journal ArticleDOI
Advances and recent developments in asthma in 2020.
Lacin Cevhertas,Lacin Cevhertas,Ismail Ogulur,Ismail Ogulur,Debbie J Maurer,Daniel Burla,Mei Ding,Mei Ding,Kirstin Jansen,Jana Koch,Chengyao Liu,Siyuan Ma,Yasutaka Mitamura,Yaqi Peng,Urszula Radzikowska,Urszula Radzikowska,Arturo Rinaldi,Pattraporn Satitsuksanoa,Anna Głobińska,Willem van de Veen,Milena Sokolowska,Katja Baerenfaller,Ya-dong Gao,Ioana Agache,Mübeccel Akdis,Cezmi A. Akdis +25 more
TL;DR: The most relevant experimental studies further advancing the understanding of molecular and immune mechanisms with potential new targets for the development of therapeutics are discussed and critical approaches and strategies in asthma treatment linked to mechanisms and endotypes of asthma, particularly biologicals are critically appraised.
Posted ContentDOI
Distribution of ACE2, CD147, cyclophilins, CD26 and other SARS-CoV-2 associated molecules in human tissues and immune cells in health and disease
Urszula Radzikowska,Mei Ding,Ge Tan,Damir Zhakparov,Yaqi Peng,Paulina Wawrzyniak,Ming Wang,Shuo Li,Hideaki Morita,Can Altunbulakli,Matthias Reiger,Avidan U. Neumann,Nonhlanhla Lunjani,Claudia Traidl-Hoffmann,Kari C. Nadeau,Liam O'Mahony,Cezmi A. Akdis,Milena Sokolowska +17 more
TL;DR: The data suggest different receptor repertoire potentially involved in the SARS-CoV-2 infection at the epithelial barriers and in the immune cells might contribute to COVID-19 morbidity and severity patterns.